The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Precigen Inc (NASDAQ: PGEN) closed at $1.76 in the last session, down -3.30% from day before closing price of $1.82. In other words, the price has decreased by -$3.30 from its previous closing price. On the day, 1.98 million shares were traded. PGEN stock price reached its highest trading level at $1.905 during the session, while it also had its lowest trading level at $1.7401.
Ratios:
We take a closer look at PGEN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.53 and its Current Ratio is at 3.53. In the meantime, Its Debt-to-Equity ratio is 0.35 whereas as Long-Term Debt/Eq ratio is at 0.29.
On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.Cantor Fitzgerald initiated its Overweight rating on November 18, 2022, with a $7 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 09 ’24 when Perez Jeffrey Thomas bought 58,823 shares for $0.85 per share. The transaction valued at 50,000 led to the insider holds 743,097 shares of the business.
KIRK RANDAL J bought 23,529,411 shares of PGEN for $19,999,999 on Aug 09 ’24. The Director now owns 64,547,214 shares after completing the transaction at $0.85 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 519516800 and an Enterprise Value of 373848672. For the stock, the TTM Price-to-Sale (P/S) ratio is 123.70. Its current Enterprise Value per Revenue stands at 88.99 whereas that against EBITDA is -4.185.
Stock Price History:
The Beta on a monthly basis for PGEN is 1.87, which has changed by 0.09316766 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, PGEN has reached a high of $2.17, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 17.40%, while the 200-Day Moving Average is calculated to be 34.91%.
Shares Statistics:
According to the various share statistics, PGEN traded on average about 1.85M shares per day over the past 3-months and 2549350 shares per day over the past 10 days. A total of 295.14M shares are outstanding, with a floating share count of 146.25M. Insiders hold about 50.45% of the company’s shares, while institutions hold 27.29% stake in the company. Shares short for PGEN as of 1749772800 were 27281305 with a Short Ratio of 15.69, compared to 1747267200 on 28738310. Therefore, it implies a Short% of Shares Outstanding of 27281305 and a Short% of Float of 16.04.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Its stock is currently analyzed by 2.0 different market analysts. The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.07 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.37 and -$0.37 for the fiscal current year, implying an average EPS of -$0.37. EPS for the following year is $0.05, with 2.0 analysts recommending between $0.11 and -$0.01.
Revenue Estimates
A total of 4 analysts have provided revenue estimates for PGEN’s current fiscal year. The highest revenue estimate was $21M, while the lowest revenue estimate was $2.84M, resulting in an average revenue estimate of $13.7M. In the same quarter a year ago, actual revenue was $3.92MBased on 3 analysts’ estimates, the company’s revenue will be $118.1M in the next fiscal year. The high estimate is $172.4M and the low estimate is $57.7M.
